More Positive Results for Adalta, Bioshares Edition 680 (January 2017)
Read More
AdAlta receives Orphan Designation for its lead drug candidate targeting patients with idiopathic pulmonary disease
Read More
AdAlta receives Orphan Designation for AD-114
Read More
Updated presentation January 2017
Read More
AdAlta Announces Positive Pre-clinical Data Showing Lead Drug Candidate Has Broad Fibrosis Treatment Potential
Read More
Positive Pre-clinical Data
Read More
Initial Director’s Interest Notice
Read More
AdAlta Extends Board with Appointment of US-Based Non Executive Director
Read More
Director Appointment
Read More
Results of AdAlta AGM 2016
Read More